Unoprostone
![]() | |
| Clinical data | |
|---|---|
| Trade names | Rescula |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Pregnancy category |
|
| Routes of administration | Topical (eye drops) |
| ATC code | S01EE02 (WHO) |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Biological half-life | 14 min |
| Excretion | Renal |
| Identifiers | |
| |
| CAS Number |
120373-36-6 |
| PubChem (CID) | 5311236 |
| DrugBank |
DB06826 |
| ChemSpider |
4470755 |
| UNII |
6X4F561V3W |
| KEGG |
D08661 |
| ChEMBL |
CHEMBL1201407 |
| ECHA InfoCard | 100.227.145 |
| Chemical and physical data | |
| Formula | C22H38O5 |
| Molar mass | 382.534 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Unoprostone (INN) is a prostaglandin analogue. Its isopropyl ester, unoprostone isopropyl, was marketed under the trade name Rescula for the management of open-angle glaucoma and ocular hypertension, but is now discontinued in the US.[1]
References
This article is issued from Wikipedia - version of the 9/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
